CVS Health's Health Care Benefits segment, primarily Aetna, reported a strong Q1 2026 MBR of 84.6%, improving 270 basis points year over year due to better government business performance and the absence of a prior-year premium deficiency reserve. Full-year 2026 guidance remains centered at 90.5% plus or minus 50 basis points, reflecting expectations of seasonal claims pressure in later quarters. With Q2 2026 results due August 5, the evenly matched market-implied odds across 87.5%-92%+ bins highlight uncertainty around whether medical cost trends and membership mix will sustain the Q1 improvement or revert toward the guided annual rate amid ongoing utilization dynamics and competitive pressures in Medicare Advantage.
Experimentelle KI-generierte Zusammenfassung mit Polymarket-Daten. Dies ist keine Handelsberatung und spielt keine Rolle bei der Auflösung dieses Marktes. · Aktualisiert<87,5 % 60%
87,5%-89% 36%
89%-90,5% 4.5%
90,5%-92% 1.6%
NEU
NEU
30. Juli 2026
<87,5 %
60%
87,5%-89%
36%
89%-90,5%
5%
90,5%-92%
2%
Über 92 %
2%
<87,5 % 60%
87,5%-89% 36%
89%-90,5% 4.5%
90,5%-92% 1.6%
NEU
NEU
30. Juli 2026
<87,5 %
$3,392 Vol.
60%
87,5%-89%
$2,923 Vol.
36%
89%-90,5%
$335 Vol.
5%
90,5%-92%
$224 Vol.
2%
Über 92 %
$206 Vol.
2%
This market will resolve according to CVS Health's medical benefit ratio (MBR) for the upcoming second fiscal quarter, as reported in its official company earnings materials.
The specified metric will be considered as reported in the company's official earnings materials. Subsequent revisions will not be considered.
If the specified company's official earnings materials for the specified quarter are released, and the specified metric is not included, this market will resolve to the lowest bracket.
If the specified company does not release quarterly earnings materials for the specified quarter by August 31, 2026, 11:59 PM ET, this market will resolve to the lowest bracket.
If the reported value falls exactly between two brackets, this market will resolve to the higher range bracket.
If the specified metric is reported as a range rather than a specific number, the midpoint of the range will be used for resolution of this market.
The resolution source for this market is the specified company's official earnings materials, including press releases, investor presentations, and regulatory filings. If the specified metric is not reported in these materials, recordings or transcripts of the company's earnings webcast may also be used.
Note: This market will resolve based on the most numerically precise version of the specified metric reported in the company's official earnings materials. Only the specified metric will be considered; alternate versions that differ in definition or scope from the specified metric will not be considered.CVS Health's Health Care Benefits segment, primarily Aetna, reported a strong Q1 2026 MBR of 84.6%, improving 270 basis points year over year due to better government business performance and the absence of a prior-year premium deficiency reserve. Full-year 2026 guidance remains centered at 90.5% plus or minus 50 basis points, reflecting expectations of seasonal claims pressure in later quarters. With Q2 2026 results due August 5, the evenly matched market-implied odds across 87.5%-92%+ bins highlight uncertainty around whether medical cost trends and membership mix will sustain the Q1 improvement or revert toward the guided annual rate amid ongoing utilization dynamics and competitive pressures in Medicare Advantage.
This market will resolve according to CVS Health's medical benefit ratio (MBR) for the upcoming second fiscal quarter, as reported in its official company earnings materials.
The specified metric will be considered as reported in the company's official earnings materials. Subsequent revisions will not be considered.
If the specified company's official earnings materials for the specified quarter are released, and the specified metric is not included, this market will resolve to the lowest bracket.
If the specified company does not release quarterly earnings materials for the specified quarter by August 31, 2026, 11:59 PM ET, this market will resolve to the lowest bracket.
If the reported value falls exactly between two brackets, this market will resolve to the higher range bracket.
If the specified metric is reported as a range rather than a specific number, the midpoint of the range will be used for resolution of this market.
The resolution source for this market is the specified company's official earnings materials, including press releases, investor presentations, and regulatory filings. If the specified metric is not reported in these materials, recordings or transcripts of the company's earnings webcast may also be used.
Note: This market will resolve based on the most numerically precise version of the specified metric reported in the company's official earnings materials. Only the specified metric will be considered; alternate versions that differ in definition or scope from the specified metric will not be considered.
The specified metric will be considered as reported in the company's official earnings materials. Subsequent revisions will not be considered.
If the specified company's official earnings materials for the specified quarter are released, and the specified metric is not included, this market will resolve to the lowest bracket.
If the specified company does not release quarterly earnings materials for the specified quarter by August 31, 2026, 11:59 PM ET, this market will resolve to the lowest bracket.
If the reported value falls exactly between two brackets, this market will resolve to the higher range bracket.
If the specified metric is reported as a range rather than a specific number, the midpoint of the range will be used for resolution of this market.
The resolution source for this market is the specified company's official earnings materials, including press releases, investor presentations, and regulatory filings. If the specified metric is not reported in these materials, recordings or transcripts of the company's earnings webcast may also be used.
Note: This market will resolve based on the most numerically precise version of the specified metric reported in the company's official earnings materials. Only the specified metric will be considered; alternate versions that differ in definition or scope from the specified metric will not be considered.
Markt eröffnet: Jul 18, 2026, 4:13 PM ET
Volumen
$7,080Enddatum
30. Juli 2026Markt eröffnet
Jul 18, 2026, 4:13 PM ETResolver
0x69c47De9D...This market will resolve according to CVS Health's medical benefit ratio (MBR) for the upcoming second fiscal quarter, as reported in its official company earnings materials.
The specified metric will be considered as reported in the company's official earnings materials. Subsequent revisions will not be considered.
If the specified company's official earnings materials for the specified quarter are released, and the specified metric is not included, this market will resolve to the lowest bracket.
If the specified company does not release quarterly earnings materials for the specified quarter by August 31, 2026, 11:59 PM ET, this market will resolve to the lowest bracket.
If the reported value falls exactly between two brackets, this market will resolve to the higher range bracket.
If the specified metric is reported as a range rather than a specific number, the midpoint of the range will be used for resolution of this market.
The resolution source for this market is the specified company's official earnings materials, including press releases, investor presentations, and regulatory filings. If the specified metric is not reported in these materials, recordings or transcripts of the company's earnings webcast may also be used.
Note: This market will resolve based on the most numerically precise version of the specified metric reported in the company's official earnings materials. Only the specified metric will be considered; alternate versions that differ in definition or scope from the specified metric will not be considered.CVS Health's Health Care Benefits segment, primarily Aetna, reported a strong Q1 2026 MBR of 84.6%, improving 270 basis points year over year due to better government business performance and the absence of a prior-year premium deficiency reserve. Full-year 2026 guidance remains centered at 90.5% plus or minus 50 basis points, reflecting expectations of seasonal claims pressure in later quarters. With Q2 2026 results due August 5, the evenly matched market-implied odds across 87.5%-92%+ bins highlight uncertainty around whether medical cost trends and membership mix will sustain the Q1 improvement or revert toward the guided annual rate amid ongoing utilization dynamics and competitive pressures in Medicare Advantage.
This market will resolve according to CVS Health's medical benefit ratio (MBR) for the upcoming second fiscal quarter, as reported in its official company earnings materials.
The specified metric will be considered as reported in the company's official earnings materials. Subsequent revisions will not be considered.
If the specified company's official earnings materials for the specified quarter are released, and the specified metric is not included, this market will resolve to the lowest bracket.
If the specified company does not release quarterly earnings materials for the specified quarter by August 31, 2026, 11:59 PM ET, this market will resolve to the lowest bracket.
If the reported value falls exactly between two brackets, this market will resolve to the higher range bracket.
If the specified metric is reported as a range rather than a specific number, the midpoint of the range will be used for resolution of this market.
The resolution source for this market is the specified company's official earnings materials, including press releases, investor presentations, and regulatory filings. If the specified metric is not reported in these materials, recordings or transcripts of the company's earnings webcast may also be used.
Note: This market will resolve based on the most numerically precise version of the specified metric reported in the company's official earnings materials. Only the specified metric will be considered; alternate versions that differ in definition or scope from the specified metric will not be considered.
The specified metric will be considered as reported in the company's official earnings materials. Subsequent revisions will not be considered.
If the specified company's official earnings materials for the specified quarter are released, and the specified metric is not included, this market will resolve to the lowest bracket.
If the specified company does not release quarterly earnings materials for the specified quarter by August 31, 2026, 11:59 PM ET, this market will resolve to the lowest bracket.
If the reported value falls exactly between two brackets, this market will resolve to the higher range bracket.
If the specified metric is reported as a range rather than a specific number, the midpoint of the range will be used for resolution of this market.
The resolution source for this market is the specified company's official earnings materials, including press releases, investor presentations, and regulatory filings. If the specified metric is not reported in these materials, recordings or transcripts of the company's earnings webcast may also be used.
Note: This market will resolve based on the most numerically precise version of the specified metric reported in the company's official earnings materials. Only the specified metric will be considered; alternate versions that differ in definition or scope from the specified metric will not be considered.
Volumen
$7,080Enddatum
30. Juli 2026Markt eröffnet
Jul 18, 2026, 4:13 PM ETResolver
0x69c47De9D...CVS Health's Health Care Benefits segment, primarily Aetna, reported a strong Q1 2026 MBR of 84.6%, improving 270 basis points year over year due to better government business performance and the absence of a prior-year premium deficiency reserve. Full-year 2026 guidance remains centered at 90.5% plus or minus 50 basis points, reflecting expectations of seasonal claims pressure in later quarters. With Q2 2026 results due August 5, the evenly matched market-implied odds across 87.5%-92%+ bins highlight uncertainty around whether medical cost trends and membership mix will sustain the Q1 improvement or revert toward the guided annual rate amid ongoing utilization dynamics and competitive pressures in Medicare Advantage.
Experimentelle KI-generierte Zusammenfassung mit Polymarket-Daten. Dies ist keine Handelsberatung und spielt keine Rolle bei der Auflösung dieses Marktes. · Aktualisiert
Vorsicht bei externen Links.
Vorsicht bei externen Links.
Häufig gestellte Fragen